The Stolen Focus Roadmap to Regain Your Attention
A summary of Stolen Focus and how to regain your attention
Your missing action plan to Outlive by Dr. Peter Attia. A guide to prioritize risks, personalize strategy, and outlive disease.
Pathway / Horseman (System Deaths/yr) | Linked Key Diseases (Deaths/yr) & Associated Conditions | Assessment Focus & Metrics (Quick /// Comprehensive) | Key Risk Factors (Sorted High-Low Score Approx.) | Avg-Risk Screen Caught? Silent Progression? |
1. Cardiovascular / Horseman #1 (Atherosclerosis) | Primary: Atherosclerosis -> CAD/MI (~700k/yr), Stroke (~160k/yr). | Primary Mortality Focus (MI, Stroke): BP (<115/75 mmHg); Triglycerides (<80 mg/dL) LDL Cholesterol (<80 mg/dL) /// ApoB (<30-70 mg/dL)*, CAC Score (0) **cholesterol, HDL, and LDL, while important are deprioritized since they’re less reliable than the above measures | HTN (5), Smoking Hx (5), High ApoB/LDL (5), Age (4), Diabetes (4), Genetics (3), Sedentary (3), Poor Diet (3) | Yes (BP; AAA risk groups) / Yes (Atherosclerosis) |
(~991k+ total CV deaths) | Associated Conditions Assessed: HTN, Afib (~26k/yr), AAA Rupture (~5k/yr). | Contributing Risk / Condition Focus (Afib, AAA): ECG (check arrhythmias and ischemic changes; Quick ECG covers some Afib) /// Holter Monitor (If symptoms), AAA US (Risk-based) | ㅤ | ㅤ |
--- | --- | --- | --- | --- |
2. Cancer / Horseman #2 (Cancer) | Primary: See Cancer Map (Part 2) for major killers. Total ~348k+/yr across major cancers listed. | Refer to Longevity Cancer Coverage Map (Part 2) (Metrics inherently target primary mortality risk for each specific cancer listed) | Refer to Longevity Cancer Coverage Map (Part 2) (Varies by cancer type) | Refer to Longevity Cancer Coverage Map (Part 2) |
(~348k+ total related deaths from Map) | (No separate 'Contributing Risk' category as metrics target primary cancer risk directly) | ㅤ | ㅤ | (Varies by cancer type) |
--- | --- | --- | --- | --- |
3. Neuro-Endo-Stress / Horseman #3 (Neurodegeneration) | Primary: Cognitive Decline/Dementia (AD proxy ~135k/yr). | Primary Mortality Focus (Dementia): Cog Screen /// Neuroimaging? (Symptom/indication based) | Age (5), Genetics (4), Vascular Disease (#1) (4), Hearing/Vision Loss (3), Poor Sleep (3), Chronic Stress (3) | No/limited / Yes (Cognitive decline often gradual/silent) |
(~185k+ total deaths listed) | Associated Conditions Assessed: Mood Disorders/Suicide (~50k/yr), Hearing Loss, Sleep Disorders, Thyroid Dysfunction. | Contributing Risk / Healthspan Focus (Mood, Sensory, Sleep, Thyroid): Hearing Screen, Mental Health Screens, Sleep Quest.(>7.5h qual?)*, TSH /// Audiogram, Psych Eval, Actigraphy/PSG, Free T4/Abs | Thyroid Issues (2) | ㅤ |
--- | --- | --- | --- | --- |
4. Metabolic / Horseman #4 (Metabolic Dysfunction) | Primary: Type 2 Diabetes (~103k), NAFLD/NASH -> CLD/Cirrhosis (~57k). Note: Major driver of CVD (#1) & CKD (#5) risk. | Primary Mortality Focus (Diabetes, Cirrhosis): HbA1c** (<5.3%), Liver US/FibroScan **is one of the most reliable indicators and easily obtainable through a blood test. As a result, I remove FBG, which is a less reliable indicator. | Obesity/Visceral Fat (5), Poor Diet (High Sugar/Processed) (5), Sedentary (4), Age (3), Genetics (3) | Yes (Diabetes Risk Screen) / Yes (Insulin resistance/NAFLD) |
(~160k+ total related deaths listed) | Associated Conditions Assessed: Components of Metabolic Syndrome. | Contributing Risk / Condition Focus (Metabolic Syndrome Components): Waist Circ., BP (Covered in #1) | ㅤ | ㅤ |
--- | --- | --- | --- | --- |
5. Organ & System Integrity | Primary: CKD (~55k), Osteoporosis / Fracture Risk (~35k proxy via complications). | Primary Mortality Focus (CKD, Fracture Complications): eGFR, Urinalysis, FRAX /// UACR, DEXA | Age (5), Low Activity (4), CKD Risk (Diabetes, HTN) (4), Poor Nutrition (3), Smoking (3), Low Estrogen (3) | Yes (Osteoporosis DEXA Screen) / Yes (CKD, Osteoporosis) |
(~90k+ total deaths listed) | Associated Conditions Assessed: Frailty, Glaucoma, Low Fitness (VO2 Max). | Contributing Risk / Healthspan Focus (Frailty, Vision, Fitness): Grip/Gait, Vision Screen, Activity Level /// Eye Exam, CGA, CPET/Accel.(High VO2 Max Target- for age 20s-30s: 50-60 mL/kg/min) | ㅤ | ㅤ |
--- | --- | --- | --- | --- |
6. Inflammation & Immune Health | Primary: None directly. Role: Amplifies risk for ALL Horsemen (esp. #1). | Primary Impact Focus (Systemic Inflammation as Risk Amplifier): hs-CRP (<0.5-1.0 mg/L)* | Chronic Infection (Periodontal) (4), Obesity (4), Poor Diet (4), Smoking (3), Chronic Stress (3) | No (hs-CRP measures status) / Yes (Inflammation) |
(0 direct deaths, but amplifies other risks) | Associated Conditions Assessed: Periodontal Disease, Immune Dysregulation. | Contributing Risk / Condition Focus (Oral Health Link): --- /// Periodontal Exam | Autoimmune conditions (Variable) | ㅤ |
Cancer Type (~Deaths/yr) | Key Risk Factors (Score 1-5) | Quick & Comprehensive Metrics (Initial /// Comprehensive) | Potential Detection: MCED* / Imaging? | Avg-Risk Screen & Symptom Onset |
Lung Cancer (~130k) | Radon (4), Occup. exposures (3-4), Secondhand smoke (3), Family Hx (2-3), Prior lung disease (2), Air pollution / Fumes / Cooking Meat (2) | Risk Assessment (Ongoing) /// LDCT (50+ by request, NON-Guideline for non-smoker) | MCED*, LDCT, CT, PET | No (Non-Smoker) / Yes (Silent) |
Colorectal (CRC) (~53k) | Age (4), IBD (4), Family Hx (3-4), Diet (Proc./Red Meat ↑, Fiber ↓) (3), Obesity (3), Alcohol (2) | FIT (40); Risk Assessment /// Colonoscopy (40-45) | MCED*, CT, MRI, PET (Staging/Recur.) | Yes / Yes (Silent) |
Pancreatic (~51k) | Smoking Hx (past) (5), Chronic Pancreatitis (4), Family Hx (4), New Diabetes >50 (3), Obesity (2-3) | Risk Assessment (Ongoing) /// EUS / MRI (Primarily high-risk genetic syndromes or symptoms) | MCED*, US (EUS), MRI, CT, PET | No / Yes (Very Silent) |
Prostate (~35k) | Age (4), Family Hx (3-4), African Ancestry (3) | PSA (40-45); DRE /// MRI/Biopsy (If PSA high or suspicious DRE) | MCED*, MRI, CT, PET (Staging) | Yes (Shared Decision) / Variable |
Liver (HCC) (~30k) | Chronic Hep C/B (5), Cirrhosis (5), Alcohol (4-5), NAFLD/NASH (4), Hemochromatosis (3), Aflatoxin (3) | Hep C Ab Test (18+); ALT/AST (Assess NAFLD Risk - 35); Risk Assessment /// HCV RNA Test (If Ab+); Liver US/Elastography (Risk factors); AFP Blood Test? (High risk surveillance only) | MCED*, US, CT, MRI | No (Risk Factors Only) / Yes (Silent) |
Leukemia (~23k) | Prior Chemo/Radiation (4), Genetic Syndromes (4), Benzene exposure (3-4) | CBC w/ Diff (Baseline Young Adult); Risk Assessment /// Bone Marrow Biopsy (If indicated) | MCED* | No / Variable (Acute rapid) |
Non-Hodgkin Lymphoma (~20k) | Immune Suppression (4), Age (3), Infections (HIV, EBV) (3), Pesticides (2-3), Family Hx (2) | Risk Assessment (Ongoing) /// Lymph Node Biopsy (If indicated); Assess Incidental Imaging Findings | MCED*, CT, PET, MRI | No / Variable |
Brain & Nervous Sys. (~19k) | Radiation Exposure (4), Family Hx (rare syndromes) (4), Age (3) | Risk Assessment (Ongoing) /// MRI / CT of Brain (If indicated by symptoms) | MCED*, MRI, CT | No / Variable (Symptoms often prompt Dx) |
Bladder (~18k) | Smoking (Primary) (5), Occup. Exposures (Aromatic Amines) (4), Age (3), Family Hx (2), Chronic UTIs (2) | Urinalysis (40 - low spec.); Urine Biomarker Tests?* (Discuss w/ MD); Risk Assessment (Exposures) /// Cystoscopy (If indicated) | MCED*, CT, MRI (Staging) | No / Variable (Hematuria often early) |
Esophageal (~16k) | Barrett's (5), Smoking (N/A here) (5), Alcohol (+ALDH2 Def.) (3-4), Chronic GERD (3), Obesity (3), Hot Liquids (2?) | Risk Assessment (GERD/Barrett's Hx); Cytosponge?* (Discuss w/ MD) /// Upper Endoscopy (Surveillance if Barrett's; or symptoms) | MCED*, CT, PET, US (EUS) (Staging) | No / Yes (Silent) |
Kidney (~14k) | Smoking (N/A here) (4), Obesity (3), Hypertension (3), Family Hx (3), Dialysis (3), Exposures (2) | Urinalysis (40 - low spec.); Risk Assessment (Ongoing) /// Abdominal US / CT / MRI (Often incidental; surveillance if high risk) | MCED*, US, CT, MRI | No / Yes (Often Silent) |
Multiple Myeloma (~13k) | MGUS Precursor (5), Age (4), African Ancestry (3), Male Sex (2), Family Hx (2), Obesity? (1-2) | Risk Assess. (MGUS Hx?); Basic Blood/Urine Tests (CBC, Ca, Protein, Kidney Func. - 40s) /// SPEP/UPEP/sFLC (Specific protein tests - 40s? If risk/suspicion); Bone Marrow Biopsy (If indicated) | MCED*, CT, MRI, PET (Bone lesions) | No / Yes (Often presents w/ complications) |
Stomach (Gastric) (~11k) | H. pylori (4), Family Hx (3), Diet (High Salt/Smoked/Pickled) (3), Pernicious Anemia (2) | Risk Assessment (Diet, H. pylori status?) /// Upper Endoscopy w/ Biopsy (If high risk or symptoms) | MCED*, CT, PET, US (EUS) (Staging) | No / Yes (Silent) |
Oral (~11k) | Tobacco (N/A here) (5), Heavy Alcohol Use (4), HPV Infection (4) | Annual Dental Visit / Self-Awareness /// Oral Exam (Dentist) (Annually); Biopsy (If lesion found) | MCED* (Primarily visual exam) | Yes (Visual Exam) / No |
Skin (Melanoma) (~8k) | UV Exposure (5), Many/Atypical Moles (4), Fair Skin (3), Family Hx (3), Immune Suppression (3) | Skin Self-Exam (Teenager+) /// Clinician Skin Exam (20s); Biopsy (If suspicious) | MCED* (Primarily visual exam) | Yes (Visual Exam) / No |
Thyroid (~2k) | Radiation (childhood) (4), Genetic Syndromes (4), Family Hx (3-4), Female Sex (3), Age (20-55) (3) | Neck Self-Exam / Clinical Neck Palpation (Ongoing); TSH /// Thyroid US (If nodule/suspicious); Fine Needle Aspiration Biopsy (If indicated by US) | MCED*, US | No / No (Usually slow/good prognosis) |
Testicular (~0.5k) | Undescended Testicle Hx (4), Age (15-35 Peak) (4), Family Hx (3), White Race (2) | Testicular Self-Exam (Monthly from Teenager) /// Scrotal US; Tumor Marker Blood Tests (AFP, hCG, LDH) (If mass found) | MCED*, US, CT (Staging) | No (Self-Exam Rec.) / No |